IN2014CN03951A - - Google Patents

Info

Publication number
IN2014CN03951A
IN2014CN03951A IN3951CHN2014A IN2014CN03951A IN 2014CN03951 A IN2014CN03951 A IN 2014CN03951A IN 3951CHN2014 A IN3951CHN2014 A IN 3951CHN2014A IN 2014CN03951 A IN2014CN03951 A IN 2014CN03951A
Authority
IN
India
Prior art keywords
terpenoid
ophthalmological
inhibitory activity
aqueous composition
suppressing
Prior art date
Application number
Inventor
Yasuko Matsumura
Chinatsu Furumiya
Masashi Itoh
Original Assignee
Rohto Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma filed Critical Rohto Pharma
Publication of IN2014CN03951A publication Critical patent/IN2014CN03951A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

The present invention provides an ophthalmological aqueous composition containing a terpenoid and zinc chloride and having a pH of 7 or more. This ophthalmological aqueous composition: is capable of suppressing a decrease over the long term in the amount of the terpenoid contained by suppressing adsorption of the terpenoid by a container; and furthermore has excellent histamine release inhibitory activity rheum inhibitory activity and the like.
IN3951CHN2014 2011-11-01 2012-10-31 IN2014CN03951A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011240145 2011-11-01
PCT/JP2012/078126 WO2013065719A1 (en) 2011-11-01 2012-10-31 Ophthalmological aqueous composition

Publications (1)

Publication Number Publication Date
IN2014CN03951A true IN2014CN03951A (en) 2015-09-04

Family

ID=48192064

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3951CHN2014 IN2014CN03951A (en) 2011-11-01 2012-10-31

Country Status (5)

Country Link
US (1) US20140296348A1 (en)
JP (2) JP6313598B2 (en)
CA (1) CA2853233A1 (en)
IN (1) IN2014CN03951A (en)
WO (1) WO2013065719A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853233A1 (en) * 2011-11-01 2013-05-10 Rohto Pharmaceutical Co., Ltd. Ophthalmological aqueous composition
JP6081173B2 (en) * 2011-12-12 2017-02-15 ロート製薬株式会社 Ophthalmic aqueous composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003146892A (en) * 2001-11-08 2003-05-21 Rohto Pharmaceut Co Ltd Cleaning agent
JP4953650B2 (en) * 2005-02-09 2012-06-13 ロート製薬株式会社 Planoprofen-containing composition
US8388941B2 (en) * 2006-09-28 2013-03-05 Alcon Research, Ltd. Self preserved aqueous pharmaceutical compositions
JP5314349B2 (en) * 2007-07-25 2013-10-16 ロート製薬株式会社 Ophthalmic composition
JP4777477B2 (en) * 2009-09-30 2011-09-21 ロート製薬株式会社 Eye drops
CA2853233A1 (en) * 2011-11-01 2013-05-10 Rohto Pharmaceutical Co., Ltd. Ophthalmological aqueous composition

Also Published As

Publication number Publication date
JP2017052803A (en) 2017-03-16
JP6253756B2 (en) 2017-12-27
CA2853233A1 (en) 2013-05-10
US20140296348A1 (en) 2014-10-02
JPWO2013065719A1 (en) 2015-04-02
JP6313598B2 (en) 2018-04-18
WO2013065719A1 (en) 2013-05-10

Similar Documents

Publication Publication Date Title
IN2014CN03950A (en)
IL235966B (en) Aqueous compositions having ph of 6.0 comprising non-fucosylated anti-baffr antibody for use in the treatment of autoimmune diseases
WO2013075826A3 (en) Use of isosorbide caprylates/caprates in deodorants and antiperspirants
MX351464B (en) Methods for the treatment of allergic diseases.
IL231591A0 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
PH12015500780A1 (en) Rsv antiviral compounds
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
ZA201408295B (en) Composition comprising a biological control agent and a fungicide selected from inhibitors of the ergosterol biosynthesis
HUE026603T2 (en) The use of a composition having biocide activity for aqueous preparations and a process for bacterial stabilizing such aqueous preparations
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
PT2869854T (en) Composition containing ecotine or hydroxyecotine as an active substances for promoting the regeneration of injured body tissue
WO2011039735A3 (en) Compounds with ddx3 inhibitory activity and uses thereof
PH12014502187A1 (en) Cdr-modified anti-siglec-15 antibody
MX345458B (en) Antifungal compositions for the treatment of skin and nails.
IN2012DN05192A (en)
MX2015011359A (en) Macrocyclic lrrk2 kinase inhibitors.
WO2013045270A3 (en) Antiperspirant compositions and method for reducing perspiration
MX2015012526A (en) Macrocyclic rip2 kinase inhibitors.
IL224029A (en) Triazines and pyrimidines , compositions comprising same and use thereof for the treatment of insects
PH12017500516A1 (en) Compositions
IN2014CN03951A (en)
MX2013008277A (en) Bromfenac aqueous liquid composition having preservative efficiency.
ZA201500285B (en) Biocidal compositions and their use in the control of microorganisms in aqueous and water containing systems
MY182059A (en) Pharmaceutical composition for external use
WO2012069061A3 (en) A shaving composition for pseudofolliculitis barbae treatment